Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer.

Newton TR, Parsons PG, Lincoln DJ, Cummings MC, Wyld DK, Webb PM, Green AC, Boyle GM.

Int J Cancer. 2006 Aug 15;119(4):875-83.

PMID:
16557592
[PubMed - indexed for MEDLINE]
2.

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.

Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, Aoki Y, Ishii N, Yanaihara N, Yamada K, Takikawa O, Kawaguchi R, Isonishi S, Tanaka T, Urashima M.

Clin Cancer Res. 2005 Aug 15;11(16):6030-9.

PMID:
16115948
[PubMed - indexed for MEDLINE]
Free Article
3.

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.

Hartmann LC, Lu KH, Linette GP, Cliby WA, Kalli KR, Gershenson D, Bast RC, Stec J, Iartchouk N, Smith DI, Ross JS, Hoersch S, Shridhar V, Lillie J, Kaufmann SH, Clark EA, Damokosh AI.

Clin Cancer Res. 2005 Mar 15;11(6):2149-55.

PMID:
15788660
[PubMed - indexed for MEDLINE]
Free Article
4.

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

Spentzos D, Levine DA, Kolia S, Otu H, Boyd J, Libermann TA, Cannistra SA.

J Clin Oncol. 2005 Nov 1;23(31):7911-8. Epub 2005 Oct 3.

PMID:
16204010
[PubMed - indexed for MEDLINE]
Free Article
5.

WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.

Netinatsunthorn W, Hanprasertpong J, Dechsukhum C, Leetanaporn R, Geater A.

BMC Cancer. 2006 Apr 11;6:90.

PMID:
16606472
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.

Yoshihara K, Tajima A, Komata D, Yamamoto T, Kodama S, Fujiwara H, Suzuki M, Onishi Y, Hatae M, Sueyoshi K, Fujiwara H, Kudo Y, Inoue I, Tanaka K.

Cancer Sci. 2009 Aug;100(8):1421-8. doi: 10.1111/j.1349-7006.2009.01204.x. Epub 2009 May 26.

PMID:
19486012
[PubMed - indexed for MEDLINE]
7.

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.

Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett JC, Boyd J.

Clin Cancer Res. 2005 Sep 1;11(17):6300-10.

PMID:
16144934
[PubMed - indexed for MEDLINE]
Free Article
8.

Gene expression profiles as prognostic markers in women with ovarian cancer.

Jochumsen KM, Tan Q, Høgdall EV, Høgdall C, Kjaer SK, Blaakaer J, Kruse TA, Mogensen O.

Int J Gynecol Cancer. 2009 Oct;19(7):1205-13. doi: 10.1111/IGC.0b013e3181a3cf55.

PMID:
19823056
[PubMed - indexed for MEDLINE]
9.

Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.

Bachvarov D, L'esperance S, Popa I, Bachvarova M, Plante M, Têtu B.

Int J Oncol. 2006 Oct;29(4):919-33.

PMID:
16964388
[PubMed - indexed for MEDLINE]
10.

Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.

Eitan R, Kushnir M, Lithwick-Yanai G, David MB, Hoshen M, Glezerman M, Hod M, Sabah G, Rosenwald S, Levavi H.

Gynecol Oncol. 2009 Aug;114(2):253-9. doi: 10.1016/j.ygyno.2009.04.024. Epub 2009 May 14.

PMID:
19446316
[PubMed - indexed for MEDLINE]
11.

Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.

Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H.

Cancer Invest. 2008 Mar;26(2):185-92. doi: 10.1080/07357900701638343.

PMID:
18259951
[PubMed - indexed for MEDLINE]
12.

Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

Choi YL, Kim J, Kwon MJ, Choi JS, Kim TJ, Bae DS, Koh SS, In YH, Park YW, Kim SH, Ahn G, Shin YK.

Histol Histopathol. 2007 Nov;22(11):1185-95.

PMID:
17647191
[PubMed - indexed for MEDLINE]
13.

Gene expression patterns that characterize advanced stage serous ovarian cancers.

Lancaster JM, Dressman HK, Whitaker RS, Havrilesky L, Gray J, Marks JR, Nevins JR, Berchuck A.

J Soc Gynecol Investig. 2004 Jan;11(1):51-9.

PMID:
14706684
[PubMed - indexed for MEDLINE]
14.

Expression profiling and individualisation of treatment for ovarian cancer.

Agarwal R, Kaye SB.

Curr Opin Pharmacol. 2006 Aug;6(4):345-9. Epub 2006 Jun 5. Review.

PMID:
16750423
[PubMed - indexed for MEDLINE]
15.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
16.

Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas.

Têtu B, Popa I, Bairati I, L'Esperance S, Bachvarova M, Plante M, Harel F, Bachvarov D.

Mod Pathol. 2008 Aug;21(8):1002-10. doi: 10.1038/modpathol.2008.80. Epub 2008 May 23.

PMID:
18500265
[PubMed - indexed for MEDLINE]
Free Article
17.

ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome.

Surowiak P, Materna V, Kaplenko I, Spaczynski M, Dolinska-Krajewska B, Gebarowska E, Dietel M, Zabel M, Lage H.

Clin Cancer Res. 2006 Dec 1;12(23):7149-58.

PMID:
17145840
[PubMed - indexed for MEDLINE]
Free Article
18.

Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival.

Raspollini MR, Amunni G, Villanucci A, Boddi V, Taddei GL.

Int J Gynecol Cancer. 2005 Mar-Apr;15(2):255-60.

PMID:
15823108
[PubMed - indexed for MEDLINE]
19.

Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.

Noske A, Weichert W, Niesporek S, Röske A, Buckendahl AC, Koch I, Sehouli J, Dietel M, Denkert C.

Cancer. 2008 Apr 15;112(8):1733-43. doi: 10.1002/cncr.23354.

PMID:
18306389
[PubMed - indexed for MEDLINE]
Free Article
20.

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I; Australian Ovarian Cancer Study Group, Gertig D, DeFazio A, Bowtell DD.

Clin Cancer Res. 2008 Aug 15;14(16):5198-208. doi: 10.1158/1078-0432.CCR-08-0196.

PMID:
18698038
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk